Pharmaceutical giant Pfizer and French vaccine maker Valneva reported positive topline results from their phase three study of a vaccine candidate for Lyme disease.
U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than ​70% efficacy in a late-stage trial.
NEW YORK & LYON, France--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced topline results from the Phase 3 VALOR “Vaccine Against Lyme for
Nordea Investment Management AB cut its stake in Pfizer Inc. (NYSE: PFE) by 20.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commiss
These companies have faced tough times, but better days lie ahead. They both have taken steps in recent quarters to reignite growth.

5 ‘Healthy' Dividends Paying Up To 14.1%

09:45am, Sunday, 22'nd Mar 2026
Healthcare dividend stocks are selling off with the turbulence in the Middle East.
Park Avenue Securities LLC grew its position in shares of Pfizer Inc. (NYSE: PFE) by 20.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exc
In the closing of the recent trading day, Pfizer (PFE) stood at $26.97, denoting a -1.61% move from the preceding trading day.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC (“Tutanota”) to purchase up to 1 million shares o
Pfizer's Talzenna/Xtandi combo meets phase III goals, significantly delaying disease progression in HRR-mutated metastatic castration-sensitive prostate cancer patients.

My Top 3 Drug Stocks for March 2026

06:30am, Friday, 20'th Mar 2026
Innovative drugmakers tend to perform well over the long run. These three drug stocks can launch new products while maintaining or improving their financial results.
The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes with a healthy dose of risk.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhi
AIA Group Ltd boosted its stake in Pfizer Inc. (NYSE: PFE) by 137.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The instituti
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE